A Decade of Action on AMR: Reflections and Path to 2029

A decade after the Davos Declaration on AMR, sustained collaboration has driven innovation, strengthened stewardship, and expanded access to lifesaving antibiotics and diagnostics. What began as a shared commitment by more than 100 life sciences companies has grown into the AMR Industry Alliance – setting a new benchmark for coordinated action against one of the world’s most urgent health threats.

James Anderson, Chair of AMRIA; Bruce Altevogt, AMRIA board member; and John Rex, a close partner of AMRIA; have launched a new article, A Decade of Action on AMR: Reflections and Path to 2029, highlighting measurable progress since the Declaration while making clear that resistance continues to rise. With the 2029 United Nations High-Level Meeting on AMR on the horizon, the message is clear: this is a critical window to turn commitments into lasting policy and economic reforms that can stem the rising tide of AMR.

Read the full article here: A Decade of Action on AMR: Reflections and Path to 2029

More News

In the news

WAAW Webinar 2025

News

AMR Industry Alliance Releases “Principles for Pooled Procurement of AMR Products”

News, Press Release

AMR Industry Alliance Updates Responsible Manufacturing Standard, Further Aligning with WHO Guidance